Metabolic bone diseases, particularly those associated with hyperparathyroidism and with urolithiasis and different forms of
osteoporosis are studied with regards to bone mass and turn-over, and to calcium metabolism regulation, for instance, parathyroid
hormone secretion and 1,25 dihydroxycholecalciferol synthesis.On the other hand, we study disuse osteoporosis in spinal patients, both
from the point of view of their bone mass and soft tissue composition and from that of osteoclast formation (osteoclast precursors
cultures, in coll. with the laboratory of hematology).